SecBot SecBot

WGRX

DataMeds AI, Inc.
Nasdaq· Wholesale-Drugs, Proprietaries & Druggists' Sundries· Inc. DE· CIK 0002030763 Healthcare & Medical Devices
Former ticker of DataMeds AI, Inc. · MEDS stock page →
—
Market cap
$9.3M
Nano cap
Short interest
69.7K
≈2.6% of shares · −33.7%
Days to cover
4.5
at average volume
Insider net
$0
no open-market trades · 12 mo
Filing reports
12
analyzed by SecBot
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest BEARISH DataMeds AI, Inc. filed an S-1/A registration statement for the resale of up to 34,462,057 shares of common…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • Short sellersCOVERING

    Short interest −33.7% to 69.7K shares. 4.5 days to cover, ≈2.6% of shares.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 9, 2026 SEC
DataMeds AI, Inc. filed an S-1/A registration statement for the resale of up to 34,462,057 shares of common stock by…
S-1/A — Impact 7/10
Jul 22, 2026 Listing status
Delisted: WGRX — removed from the Nasdaq symbol directory
Wellgistics Health, Inc. - Common Stock
Jun 22, 2026 Insider
Patel Prashant acquired via exercise 100,000 shares
Chief Executive Officer @ $0.005000 ($500.00)
Jun 22, 2026 Insider
Patel Prashant acquired via exercise 100,000 shares
Chief Executive Officer
Jun 22, 2026 Insider
AJJARAPU SURENDRA K acquired via exercise 100,000 shares
Director @ $0.005000 ($500.00)
May 29, 2026 SEC
Wellgistics Health raised $21.1M in a PIPE convertible note offering (net proceeds ~$16.9M after original issue…
8-K — Impact 8/10
May 21, 2026 SEC
Wellgistics Health entered a fully binding term sheet to acquire QOLPOM drone/biometric IP from EOS and SCLX, expand…
8-K — Impact 7/10

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jun 22, 2026
Patel Prashant
Chief Executive Officer
EXERCISE$500.00
Jun 22, 2026
Patel Prashant
Chief Executive Officer
EXERCISE100,000 sh
Jun 22, 2026
AJJARAPU SURENDRA K
Director
EXERCISE$500.00
Jun 22, 2026
AJJARAPU SURENDRA K
Director
EXERCISE100,000 sh
Mar 31, 2026
AJJARAPU SURENDRA K
Director
AWARD$500.00
Mar 31, 2026
AJJARAPU SURENDRA K
Director
AWARD$1.0M
Mar 31, 2026
Patel Prashant
Chief Executive Officer
AWARD$50.0K
Mar 31, 2026
Patel Prashant
Chief Executive Officer
AWARD$1.0M

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Current Q———$0.00

Short side

FINRA· Jul 15, 2026
69,712
shares short
-33.7%
vs prior settlement
4.5
days to cover
≈2.6%
of shares outstanding
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Jul 22, 2026
Listing
Delisted: WGRX — removed from the Nasdaq symbol directory
Wellgistics Health, Inc. - Common Stock
May 19, 2026
Earnings date
WGRX Q1 2026 Earnings Scheduled — 2026-05-19
May 13, 2026
Earnings date
WGRX Q1 2026 Earnings Scheduled — 2026-05-13
May 11, 2026
Earnings date
WGRX Q1 2026 Earnings Scheduled — 2026-05-11
May 4, 2026
Earnings date
WGRX Q1 2026 Earnings Scheduled — 2026-05-04

SecBot reports

12 filings · 0 bullish · 5 bearish · 2 mixed · 5 neutral
All WGRX filing & press-release reports (12)